nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Salivation—Irinotecan—lung cancer	0.0304	0.0304	CcSEcCtD
Methohexital—Thrombophlebitis—Gefitinib—lung cancer	0.0232	0.0232	CcSEcCtD
Methohexital—Injection site pain—Vinorelbine—lung cancer	0.0175	0.0175	CcSEcCtD
Methohexital—Liver function test abnormal—Teniposide—lung cancer	0.0151	0.0151	CcSEcCtD
Methohexital—Bronchospasm—Teniposide—lung cancer	0.0139	0.0139	CcSEcCtD
Methohexital—Laryngospasm—Etoposide—lung cancer	0.0131	0.0131	CcSEcCtD
Methohexital—Erythema—Pemetrexed—lung cancer	0.0122	0.0122	CcSEcCtD
Methohexital—Thrombophlebitis—Vinorelbine—lung cancer	0.012	0.012	CcSEcCtD
Methohexital—Hiccups—Irinotecan—lung cancer	0.0118	0.0118	CcSEcCtD
Methohexital—Apnoea—Etoposide—lung cancer	0.0116	0.0116	CcSEcCtD
Methohexital—Salivary hypersecretion—Irinotecan—lung cancer	0.0114	0.0114	CcSEcCtD
Methohexital—Hiccups—Cisplatin—lung cancer	0.0107	0.0107	CcSEcCtD
Methohexital—Shock—Crizotinib—lung cancer	0.0107	0.0107	CcSEcCtD
Methohexital—Anaphylactic shock—Pemetrexed—lung cancer	0.00993	0.00993	CcSEcCtD
Methohexital—Thrombophlebitis—Irinotecan—lung cancer	0.00989	0.00989	CcSEcCtD
Methohexital—Shock—Pemetrexed—lung cancer	0.00977	0.00977	CcSEcCtD
Methohexital—Shock—Gefitinib—lung cancer	0.00971	0.00971	CcSEcCtD
Methohexital—Dyspnoea—Crizotinib—lung cancer	0.00969	0.00969	CcSEcCtD
Methohexital—Hypotension—Gefitinib—lung cancer	0.00922	0.00922	CcSEcCtD
Methohexital—Agitation—Teniposide—lung cancer	0.00906	0.00906	CcSEcCtD
Methohexital—Dyspnoea—Pemetrexed—lung cancer	0.00885	0.00885	CcSEcCtD
Methohexital—Bronchospasm—Vinorelbine—lung cancer	0.00882	0.00882	CcSEcCtD
Methohexital—Dyspnoea—Gefitinib—lung cancer	0.0088	0.0088	CcSEcCtD
Methohexital—Rhinitis—Topotecan—lung cancer	0.00841	0.00841	CcSEcCtD
Methohexital—Gastrointestinal pain—Pemetrexed—lung cancer	0.00812	0.00812	CcSEcCtD
Methohexital—Gastrointestinal pain—Gefitinib—lung cancer	0.00807	0.00807	CcSEcCtD
Methohexital—Thrombophlebitis—Paclitaxel—lung cancer	0.00806	0.00806	CcSEcCtD
Methohexital—Urticaria—Pemetrexed—lung cancer	0.00789	0.00789	CcSEcCtD
Methohexital—Tachycardia—Teniposide—lung cancer	0.00785	0.00785	CcSEcCtD
Methohexital—Abdominal pain—Pemetrexed—lung cancer	0.00785	0.00785	CcSEcCtD
Methohexital—Urticaria—Gefitinib—lung cancer	0.00784	0.00784	CcSEcCtD
Methohexital—Abdominal pain—Gefitinib—lung cancer	0.0078	0.0078	CcSEcCtD
Methohexital—Liver function test abnormal—Gemcitabine—lung cancer	0.0077	0.0077	CcSEcCtD
Methohexital—Hypotension—Teniposide—lung cancer	0.00752	0.00752	CcSEcCtD
Methohexital—Erythema—Erlotinib—lung cancer	0.00723	0.00723	CcSEcCtD
Methohexital—Dyspnoea—Teniposide—lung cancer	0.00717	0.00717	CcSEcCtD
Methohexital—Bronchospasm—Gemcitabine—lung cancer	0.00709	0.00709	CcSEcCtD
Methohexital—Pruritus—Pemetrexed—lung cancer	0.00703	0.00703	CcSEcCtD
Methohexital—Pruritus—Gefitinib—lung cancer	0.00698	0.00698	CcSEcCtD
Methohexital—Apnoea—Methotrexate—lung cancer	0.00693	0.00693	CcSEcCtD
Methohexital—Vomiting—Crizotinib—lung cancer	0.00691	0.00691	CcSEcCtD
Methohexital—Thrombophlebitis—Docetaxel—lung cancer	0.00683	0.00683	CcSEcCtD
Methohexital—Gastrointestinal pain—Teniposide—lung cancer	0.00658	0.00658	CcSEcCtD
Methohexital—Convulsion—Vinblastine—lung cancer	0.00651	0.00651	CcSEcCtD
Methohexital—Nausea—Crizotinib—lung cancer	0.00645	0.00645	CcSEcCtD
Methohexital—Liver function test abnormal—Paclitaxel—lung cancer	0.00644	0.00644	CcSEcCtD
Methohexital—Urticaria—Teniposide—lung cancer	0.00639	0.00639	CcSEcCtD
Methohexital—Abdominal pain—Teniposide—lung cancer	0.00636	0.00636	CcSEcCtD
Methohexital—Vomiting—Pemetrexed—lung cancer	0.00631	0.00631	CcSEcCtD
Methohexital—Vomiting—Gefitinib—lung cancer	0.00627	0.00627	CcSEcCtD
Methohexital—Erythema—Vinorelbine—lung cancer	0.00625	0.00625	CcSEcCtD
Methohexital—Injection site pain—Doxorubicin—lung cancer	0.00623	0.00623	CcSEcCtD
Methohexital—Anxiety—Erlotinib—lung cancer	0.00613	0.00613	CcSEcCtD
Methohexital—Bronchospasm—Etoposide—lung cancer	0.00605	0.00605	CcSEcCtD
Methohexital—Anaphylactic shock—Topotecan—lung cancer	0.00596	0.00596	CcSEcCtD
Methohexital—Rhinitis—Irinotecan—lung cancer	0.00593	0.00593	CcSEcCtD
Methohexital—Delirium—Doxorubicin—lung cancer	0.00591	0.00591	CcSEcCtD
Methohexital—Nausea—Pemetrexed—lung cancer	0.0059	0.0059	CcSEcCtD
Methohexital—Nausea—Gefitinib—lung cancer	0.00586	0.00586	CcSEcCtD
Methohexital—Shock—Erlotinib—lung cancer	0.0058	0.0058	CcSEcCtD
Methohexital—Rhinitis—Gemcitabine—lung cancer	0.00578	0.00578	CcSEcCtD
Methohexital—Pruritus—Teniposide—lung cancer	0.00569	0.00569	CcSEcCtD
Methohexital—Liver function test abnormal—Docetaxel—lung cancer	0.00546	0.00546	CcSEcCtD
Methohexital—Dyspnoea—Topotecan—lung cancer	0.00531	0.00531	CcSEcCtD
Methohexital—Dyspnoea—Erlotinib—lung cancer	0.00526	0.00526	CcSEcCtD
Methohexital—Vomiting—Teniposide—lung cancer	0.00511	0.00511	CcSEcCtD
Methohexital—Anaphylactic shock—Vinorelbine—lung cancer	0.0051	0.0051	CcSEcCtD
Methohexital—Hiccups—Doxorubicin—lung cancer	0.00509	0.00509	CcSEcCtD
Methohexital—Headache—Teniposide—lung cancer	0.00504	0.00504	CcSEcCtD
Methohexital—Bronchospasm—Docetaxel—lung cancer	0.00503	0.00503	CcSEcCtD
Methohexital—Erythema—Gemcitabine—lung cancer	0.00502	0.00502	CcSEcCtD
Methohexital—Gastrointestinal pain—Vinblastine—lung cancer	0.00502	0.00502	CcSEcCtD
Methohexital—Tachycardia—Vinorelbine—lung cancer	0.00498	0.00498	CcSEcCtD
Methohexital—Salivary hypersecretion—Doxorubicin—lung cancer	0.00494	0.00494	CcSEcCtD
Methohexital—Thrombophlebitis—Methotrexate—lung cancer	0.00493	0.00493	CcSEcCtD
Methohexital—Gastrointestinal pain—Topotecan—lung cancer	0.00487	0.00487	CcSEcCtD
Methohexital—Abdominal pain—Vinblastine—lung cancer	0.00485	0.00485	CcSEcCtD
Methohexital—Rhinitis—Paclitaxel—lung cancer	0.00484	0.00484	CcSEcCtD
Methohexital—Gastrointestinal pain—Erlotinib—lung cancer	0.00482	0.00482	CcSEcCtD
Methohexital—Nausea—Teniposide—lung cancer	0.00478	0.00478	CcSEcCtD
Methohexital—Hypotension—Vinorelbine—lung cancer	0.00477	0.00477	CcSEcCtD
Methohexital—Urticaria—Topotecan—lung cancer	0.00474	0.00474	CcSEcCtD
Methohexital—Abdominal pain—Topotecan—lung cancer	0.00471	0.00471	CcSEcCtD
Methohexital—Erythema—Cisplatin—lung cancer	0.00468	0.00468	CcSEcCtD
Methohexital—Abdominal pain—Erlotinib—lung cancer	0.00466	0.00466	CcSEcCtD
Methohexital—Dyspnoea—Vinorelbine—lung cancer	0.00455	0.00455	CcSEcCtD
Methohexital—Thrombophlebitis—Doxorubicin—lung cancer	0.00426	0.00426	CcSEcCtD
Methohexital—Pruritus—Topotecan—lung cancer	0.00422	0.00422	CcSEcCtD
Methohexital—Anaphylactic shock—Irinotecan—lung cancer	0.00421	0.00421	CcSEcCtD
Methohexital—Erythema—Paclitaxel—lung cancer	0.0042	0.0042	CcSEcCtD
Methohexital—Pruritus—Erlotinib—lung cancer	0.00417	0.00417	CcSEcCtD
Methohexital—Gastrointestinal pain—Vinorelbine—lung cancer	0.00417	0.00417	CcSEcCtD
Methohexital—Shock—Irinotecan—lung cancer	0.00414	0.00414	CcSEcCtD
Methohexital—Rhinitis—Docetaxel—lung cancer	0.0041	0.0041	CcSEcCtD
Methohexital—Anaphylactic shock—Gemcitabine—lung cancer	0.0041	0.0041	CcSEcCtD
Methohexital—Convulsion—Cisplatin—lung cancer	0.00405	0.00405	CcSEcCtD
Methohexital—Urticaria—Vinorelbine—lung cancer	0.00405	0.00405	CcSEcCtD
Methohexital—Abdominal pain—Vinorelbine—lung cancer	0.00403	0.00403	CcSEcCtD
Methohexital—Anxiety—Cisplatin—lung cancer	0.00397	0.00397	CcSEcCtD
Methohexital—Liver function test abnormal—Methotrexate—lung cancer	0.00394	0.00394	CcSEcCtD
Methohexital—Hypotension—Irinotecan—lung cancer	0.00393	0.00393	CcSEcCtD
Methohexital—Vomiting—Vinblastine—lung cancer	0.0039	0.0039	CcSEcCtD
Methohexital—Agitation—Paclitaxel—lung cancer	0.00386	0.00386	CcSEcCtD
Methohexital—Headache—Vinblastine—lung cancer	0.00384	0.00384	CcSEcCtD
Methohexital—Hypotension—Gemcitabine—lung cancer	0.00383	0.00383	CcSEcCtD
Methohexital—Anaphylactic shock—Cisplatin—lung cancer	0.00382	0.00382	CcSEcCtD
Methohexital—Vomiting—Topotecan—lung cancer	0.00379	0.00379	CcSEcCtD
Methohexital—Vomiting—Erlotinib—lung cancer	0.00375	0.00375	CcSEcCtD
Methohexital—Dyspnoea—Irinotecan—lung cancer	0.00375	0.00375	CcSEcCtD
Methohexital—Headache—Topotecan—lung cancer	0.00373	0.00373	CcSEcCtD
Methohexital—Tachycardia—Cisplatin—lung cancer	0.00373	0.00373	CcSEcCtD
Methohexital—Convulsion—Etoposide—lung cancer	0.00371	0.00371	CcSEcCtD
Methohexital—Headache—Erlotinib—lung cancer	0.00369	0.00369	CcSEcCtD
Methohexital—Dyspnoea—Gemcitabine—lung cancer	0.00365	0.00365	CcSEcCtD
Methohexital—Nausea—Vinblastine—lung cancer	0.00364	0.00364	CcSEcCtD
Methohexital—Convulsion—Paclitaxel—lung cancer	0.00364	0.00364	CcSEcCtD
Methohexital—Pruritus—Vinorelbine—lung cancer	0.00361	0.00361	CcSEcCtD
Methohexital—Hypotension—Cisplatin—lung cancer	0.00357	0.00357	CcSEcCtD
Methohexital—Anxiety—Paclitaxel—lung cancer	0.00357	0.00357	CcSEcCtD
Methohexital—Erythema—Docetaxel—lung cancer	0.00356	0.00356	CcSEcCtD
Methohexital—Nausea—Topotecan—lung cancer	0.00354	0.00354	CcSEcCtD
Methohexital—Nausea—Erlotinib—lung cancer	0.0035	0.0035	CcSEcCtD
Methohexital—Anaphylactic shock—Etoposide—lung cancer	0.0035	0.0035	CcSEcCtD
Methohexital—Gastrointestinal pain—Irinotecan—lung cancer	0.00344	0.00344	CcSEcCtD
Methohexital—Anaphylactic shock—Paclitaxel—lung cancer	0.00343	0.00343	CcSEcCtD
Methohexital—Tachycardia—Etoposide—lung cancer	0.00341	0.00341	CcSEcCtD
Methohexital—Liver function test abnormal—Doxorubicin—lung cancer	0.00341	0.00341	CcSEcCtD
Methohexital—Dyspnoea—Cisplatin—lung cancer	0.0034	0.0034	CcSEcCtD
Methohexital—Shock—Paclitaxel—lung cancer	0.00337	0.00337	CcSEcCtD
Methohexital—Tachycardia—Paclitaxel—lung cancer	0.00335	0.00335	CcSEcCtD
Methohexital—Abdominal pain—Irinotecan—lung cancer	0.00332	0.00332	CcSEcCtD
Methohexital—Hypotension—Etoposide—lung cancer	0.00327	0.00327	CcSEcCtD
Methohexital—Vomiting—Vinorelbine—lung cancer	0.00324	0.00324	CcSEcCtD
Methohexital—Hypotension—Paclitaxel—lung cancer	0.00321	0.00321	CcSEcCtD
Methohexital—Headache—Vinorelbine—lung cancer	0.00319	0.00319	CcSEcCtD
Methohexital—Dyspnoea—Etoposide—lung cancer	0.00312	0.00312	CcSEcCtD
Methohexital—Convulsion—Docetaxel—lung cancer	0.00309	0.00309	CcSEcCtD
Methohexital—Dyspnoea—Paclitaxel—lung cancer	0.00306	0.00306	CcSEcCtD
Methohexital—Nausea—Vinorelbine—lung cancer	0.00303	0.00303	CcSEcCtD
Methohexital—Anaphylactic shock—Docetaxel—lung cancer	0.00291	0.00291	CcSEcCtD
Methohexital—Pruritus—Gemcitabine—lung cancer	0.0029	0.0029	CcSEcCtD
Methohexital—Gastrointestinal pain—Etoposide—lung cancer	0.00286	0.00286	CcSEcCtD
Methohexital—Shock—Docetaxel—lung cancer	0.00286	0.00286	CcSEcCtD
Methohexital—Tachycardia—Docetaxel—lung cancer	0.00284	0.00284	CcSEcCtD
Methohexital—Gastrointestinal pain—Paclitaxel—lung cancer	0.0028	0.0028	CcSEcCtD
Methohexital—Urticaria—Etoposide—lung cancer	0.00278	0.00278	CcSEcCtD
Methohexital—Abdominal pain—Etoposide—lung cancer	0.00277	0.00277	CcSEcCtD
Methohexital—Urticaria—Paclitaxel—lung cancer	0.00272	0.00272	CcSEcCtD
Methohexital—Hypotension—Docetaxel—lung cancer	0.00272	0.00272	CcSEcCtD
Methohexital—Abdominal pain—Paclitaxel—lung cancer	0.00271	0.00271	CcSEcCtD
Methohexital—Vomiting—Irinotecan—lung cancer	0.00267	0.00267	CcSEcCtD
Methohexital—Headache—Irinotecan—lung cancer	0.00263	0.00263	CcSEcCtD
Methohexital—Vomiting—Gemcitabine—lung cancer	0.0026	0.0026	CcSEcCtD
Methohexital—Dyspnoea—Docetaxel—lung cancer	0.00259	0.00259	CcSEcCtD
Methohexital—Erythema—Methotrexate—lung cancer	0.00257	0.00257	CcSEcCtD
Methohexital—Headache—Gemcitabine—lung cancer	0.00257	0.00257	CcSEcCtD
Methohexital—Rhinitis—Doxorubicin—lung cancer	0.00256	0.00256	CcSEcCtD
Methohexital—Nausea—Irinotecan—lung cancer	0.0025	0.0025	CcSEcCtD
Methohexital—Pruritus—Etoposide—lung cancer	0.00248	0.00248	CcSEcCtD
Methohexital—Nausea—Gemcitabine—lung cancer	0.00243	0.00243	CcSEcCtD
Methohexital—Vomiting—Cisplatin—lung cancer	0.00243	0.00243	CcSEcCtD
Methohexital—Pruritus—Paclitaxel—lung cancer	0.00243	0.00243	CcSEcCtD
Methohexital—Gastrointestinal pain—Docetaxel—lung cancer	0.00238	0.00238	CcSEcCtD
Methohexital—Abdominal pain—Docetaxel—lung cancer	0.0023	0.0023	CcSEcCtD
Methohexital—Nausea—Cisplatin—lung cancer	0.00227	0.00227	CcSEcCtD
Methohexital—Convulsion—Methotrexate—lung cancer	0.00222	0.00222	CcSEcCtD
Methohexital—Vomiting—Etoposide—lung cancer	0.00222	0.00222	CcSEcCtD
Methohexital—Erythema—Doxorubicin—lung cancer	0.00222	0.00222	CcSEcCtD
Methohexital—Headache—Etoposide—lung cancer	0.00219	0.00219	CcSEcCtD
Methohexital—Vomiting—Paclitaxel—lung cancer	0.00218	0.00218	CcSEcCtD
Methohexital—Headache—Paclitaxel—lung cancer	0.00215	0.00215	CcSEcCtD
Methohexital—Anaphylactic shock—Methotrexate—lung cancer	0.0021	0.0021	CcSEcCtD
Methohexital—Nausea—Etoposide—lung cancer	0.00208	0.00208	CcSEcCtD
Methohexital—Pruritus—Docetaxel—lung cancer	0.00206	0.00206	CcSEcCtD
Methohexital—Agitation—Doxorubicin—lung cancer	0.00204	0.00204	CcSEcCtD
Methohexital—Nausea—Paclitaxel—lung cancer	0.00204	0.00204	CcSEcCtD
Methohexital—Hypotension—Methotrexate—lung cancer	0.00196	0.00196	CcSEcCtD
Methohexital—Convulsion—Doxorubicin—lung cancer	0.00193	0.00193	CcSEcCtD
Methohexital—Anxiety—Doxorubicin—lung cancer	0.00189	0.00189	CcSEcCtD
Methohexital—Dyspnoea—Methotrexate—lung cancer	0.00187	0.00187	CcSEcCtD
Methohexital—Vomiting—Docetaxel—lung cancer	0.00185	0.00185	CcSEcCtD
Methohexital—Headache—Docetaxel—lung cancer	0.00182	0.00182	CcSEcCtD
Methohexital—Anaphylactic shock—Doxorubicin—lung cancer	0.00181	0.00181	CcSEcCtD
Methohexital—Shock—Doxorubicin—lung cancer	0.00179	0.00179	CcSEcCtD
Methohexital—Tachycardia—Doxorubicin—lung cancer	0.00177	0.00177	CcSEcCtD
Methohexital—Nausea—Docetaxel—lung cancer	0.00173	0.00173	CcSEcCtD
Methohexital—Gastrointestinal pain—Methotrexate—lung cancer	0.00171	0.00171	CcSEcCtD
Methohexital—Hypotension—Doxorubicin—lung cancer	0.0017	0.0017	CcSEcCtD
Methohexital—Urticaria—Methotrexate—lung cancer	0.00166	0.00166	CcSEcCtD
Methohexital—Abdominal pain—Methotrexate—lung cancer	0.00166	0.00166	CcSEcCtD
Methohexital—Dyspnoea—Doxorubicin—lung cancer	0.00162	0.00162	CcSEcCtD
Methohexital—Gastrointestinal pain—Doxorubicin—lung cancer	0.00148	0.00148	CcSEcCtD
Methohexital—Pruritus—Methotrexate—lung cancer	0.00148	0.00148	CcSEcCtD
Methohexital—Urticaria—Doxorubicin—lung cancer	0.00144	0.00144	CcSEcCtD
Methohexital—Abdominal pain—Doxorubicin—lung cancer	0.00143	0.00143	CcSEcCtD
Methohexital—Vomiting—Methotrexate—lung cancer	0.00133	0.00133	CcSEcCtD
Methohexital—Headache—Methotrexate—lung cancer	0.00131	0.00131	CcSEcCtD
Methohexital—Pruritus—Doxorubicin—lung cancer	0.00128	0.00128	CcSEcCtD
Methohexital—Nausea—Methotrexate—lung cancer	0.00124	0.00124	CcSEcCtD
Methohexital—Vomiting—Doxorubicin—lung cancer	0.00115	0.00115	CcSEcCtD
Methohexital—Headache—Doxorubicin—lung cancer	0.00114	0.00114	CcSEcCtD
Methohexital—Nausea—Doxorubicin—lung cancer	0.00108	0.00108	CcSEcCtD
